Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P04637 (
p53
)
77,613
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The pathogenesis of non-glutamatergic, depolarization-induced cell death is still enigmatic. Recently, we have shown that veratridine induces apoptosis in chromaffin cells, and we have demonstrated protective effects of antioxidants in this system, suggesting a role for Na+ channels and oxidative stress in depolarization-induced cell death. We examined the possible contribution of
p53
, a transcription factor that has a major role in determining cell fate, and the mitochondrial apoptosis pathway in veratridine-induced cell death of cultured bovine chromaffin cells. Nuclear condensation and fragmentation were detected several hours after a 60-min exposure to 30 microM veratridine. Apoptosis was associated with a transitory increase in
p53 protein
levels. Veratridine induced transcription of the pro-apoptotic p53 target gene
PUMA
, but not of bax or pig3. Using transient transfection experiments, we found that wild-type
p53
, but not the mutant form
p53
-273H, was sufficient to induce cell death in the chromaffin cells, which was caspase-9 dependent. The down-regulation of either
p53
, by overexpressing
p53
-273H, or caspase-9 activity using a dominant-negative caspase-9 mutant protected chromaffin cells against veratridine-induced toxicity. Our data demonstrate the importance of
p53
and the downstream activation of the mitochondrial apoptosis pathway in depolarization-induced apoptosis.
...
PMID:Activation of p53 and the pro-apoptotic p53 target gene PUMA during depolarization-induced apoptosis of chromaffin cells. 1611 13
Mutations in the
p53 tumor suppressor
gene occur in more than 50% of human cancers. In response to various cellular stresses, such as DNA damage, the
p53 protein
rapidly accumulates by posttranscriptional mechanism(s) and activates the expression of genes that play a major role in cellular responses leading to cell cycle arrest, DNA repair and apoptosis as a transcriptional activator. In particular, the induction of apoptosis is considered to be an important function in tumor suppression by
p53
. Recently, two BH3-only members of the Bcl-2 family, Noxa and
PUMA
, have been identified as p53 target genes. Furthermore, the analysis of mice doubly deficient in multidomain Bcl-2 family proteins, Bax and Bak, revealed that apoptosis induced by the BH3-only protein is completely dependent on Bax and Bak. More recently, it was demonstrated using gene knockout mice that Noxa and
PUMA
function as the effectors of
p53
-induced apoptosis. These analyses revealed that
p53
-induced apoptosis is regulated by these Bcl-2 family proteins. In this photogravure, the regulation of these Bcl-2 family proteins in
p53
-induced apoptosis was visualized by fluorescent protein fusion and immune fluorescence methods.
...
PMID:Involvement of Bcl-2 family proteins in p53-induced apoptosis. 1611 88
The Trp53 tumor suppressor gene product (
p53
) functions in the nucleus to regulate proapoptotic genes, whereas cytoplasmic
p53
directly activates proapoptotic Bcl-2 proteins to permeabilize mitochondria and initiate apoptosis. Here, we demonstrate that a tripartite nexus between Bcl-xL, cytoplasmic
p53
, and
PUMA
coordinates these distinct
p53
functions. After genotoxic stress, Bcl-xL sequestered cytoplasmic
p53
. Nuclear
p53
caused expression of
PUMA
, which then displaced
p53
from Bcl-xL, allowing
p53
to induce mitochondrial permeabilization. Mutant Bcl-xL that bound
p53
, but not
PUMA
, rendered cells resistant to
p53
-induced apoptosis irrespective of
PUMA
expression. Thus,
PUMA
couples the nuclear and cytoplasmic proapoptotic functions of
p53
.
...
PMID:PUMA couples the nuclear and cytoplasmic proapoptotic function of p53. 1799 94
6-Hydroxydopamine (6-OHDA) is widely used in vivo and in vitro to mimic the selective neuronal degeneration that characterizes Parkinson disease (PD). To uncover candidate genes that may mediate neuron death in PD, we previously used SAGE to identify transcripts that are rapidly induced by 6-OHDA in neuronally differentiated PC12 cells. Among induced pro-apoptotic genes was that encoding the BH3-only protein
PUMA
. Here, we confirm that 6-OHDA induces both
PUMA
mRNA and protein. 6-OHDA additionally induced Bim, another pro-apoptotic BH3-only protein. Using specific siRNAs, we demonstrate that
PUMA
, but not Bim, is required for death evoked by 6-OHDA.
PUMA
is a target of
p53
, a transcription factor activated by 6-OHDA. Involvement of
p53
in 6-OHDA evoked death was confirmed by the protective actions of a DN
p53
and pifithrin alpha, inhibitors of
p53
signaling. Our findings thus indicate that
p53
and
PUMA
play required roles in a cellular model of PD.
...
PMID:Puma and p53 play required roles in death evoked in a cellular model of Parkinson disease. 1618 18
The endoplasmic reticulum (ER) is the principal organelle for the biosynthesis of proteins, steroids and many lipids, and is highly sensitive to alterations in its environment. Perturbation of Ca(2+) homeostasis, elevated secretory protein synthesis, deprivation of glucose or other sugars, altered glycosylation and/or the accumulation of misfolded proteins may all result in ER stress, and prolonged ER stress triggers cell death. Studies from multiple laboratories have identified the roles of several ER stress-induced cell-death modulators and effectors through the use of biochemical, pharmacological and genetic tools. In the present work, we describe the role of p23, a small chaperone protein, in preventing ER stress-induced cell death. p23 is a highly conserved chaperone protein that modulates HSP90 activity and is also a component of the steroid receptors. p23 is cleaved during ER stress-induced cell death; this cleavage, which occurs close to the carboxy-terminus, requires caspase-3 and/or caspase-7, but not caspase-8. Blockage of the caspase cleavage site of p23 was associated with decreased cell death induced by ER stress. Immunodepletion of p23 or inhibition of p23 expression by siRNA resulted in enhancement of ER stress-induced cell death. While p23 co-immunoprecipitated with the BH3-only protein
PUMA
(
p53
-upregulated modulator of apoptosis) in untreated cells, prolonged ER stress disrupted this interaction. The results define a protective role for p23, and provide further support for a model in which ER stress is coupled to the mitochondrial intrinsic apoptotic pathway through the activities of BH3 family proteins.
...
PMID:Coupling endoplasmic reticulum stress to the cell-death program: a novel HSP90-independent role for the small chaperone protein p23. 1619 41
The efficacy of chemotherapeutic agents on tumor cells has been shown to be modulated by tumor suppressor gene
p53
and its target genes such as Bcl-2 family members (Bax, Noxa, and
PUMA
). However, various chemotherapeutic agents can induce cell death in tumor cells that do not express the functional
p53
, suggesting that some chemotherapeutic agents may induce cell death in a
p53
-independent pathway. Here we showed that etoposide can induce the similar degree of cell death in
p53
-deficient HCT 116 cells, whereas 5'-FU-mediated cell death is strongly dependent on the existence of functional
p53
in HCT 116 cells. Further, we provide the evidence that etoposide can induce the cytochrome c release from isolated mitochondria, and etoposide-induced cytochrome c release is not accompanied with the large amplitude swelling of mitochondria. These data suggest that etoposide can directly induce the mitochondrial dysfunction irrespective of
p53
status, and it may, at least in part, account for the
p53
-independent pathway in cell death induced by chemotherapeutic agents.
...
PMID:Release of cytochrome c from isolated mitochondria by etoposide. 1620 44
Hydroxyurea (HU) is a competitive inhibitor of ribonucleotide reductase that is used for the treatment of myeloproliferative disorders. HU inhibits DNA replication and induces apoptosis in a cell type-dependent manner, yet the relevant pathways that mediate apoptosis in response to this agent are not well characterized. In this study, we employed the human myeloid leukemia 1 (ML-1) cell line as a model to investigate the mechanisms of HU-induced apoptosis. Exposure of ML-1 cells to HU caused rapid cell death that was accompanied by hallmark features of apoptosis, including membrane blebbing, phosphatidylserine translocation, and caspase activation. HU-induced apoptosis required new protein synthesis, was induced by HU exposures as short as 15 min, and correlated with the accumulation of
p53
and induction of the p53 target gene
PUMA
.
p53
induction in ML-1 cells was ATR dependent and downregulation of
p53
through RNAi delayed HU-induced apoptosis. HU did not induce
p53
or induce apoptosis in Molt-3 leukemia cells, even though exposure to HU induced a comparable level of DNA damage and robustly activated the ATR pathway. The microtubule inhibitor nocodazole suppressed HU-induced
p53
accumulation in ML-1 cells suggesting that a microtubule-dependent event contributes to
p53
induction and apoptosis in this cell line. Our findings outline an HU-induced cell death pathway and suggest that activation of ATR is necessary, but not sufficient, for stabilization of
p53
in response to DNA replication stress.
...
PMID:ATR activation necessary but not sufficient for p53 induction and apoptosis in hydroxyurea-hypersensitive myeloid leukemia cells. 1625 78
In response to DNA damage, the
tumor suppressor p53
elicits a complex cellular response. In this issue of Cell, Wu et al. (2005) show that the transcription factor SLUG is induced by
p53
and protects hematopoietic progenitor cells from apoptosis triggered by DNA damage. SLUG exerts this protective role by repressing Puma, a proapoptotic target of
p53
.
PUMA
is also a key coordinator of apoptosis mediated by both nuclear and cytoplasmic functions of
p53
(Chi-puk et al., 2005).
...
PMID:Slugging it out: fine tuning the p53-PUMA death connection. 1628 9
Copper toxicity associated with Wilson's disease is known to cause neuronal damage and death in the basal ganglia and frontal cortex leading to Parkinson-like symptoms and cognitive deficits. Our previous work in cultured human NTERA-2-N neurons showed that copper-induced neuronal apoptosis is dependent on the induction and nuclear translocation of the tumor suppressor protein,
p53
. Because
p53
acts as a DNA-binding transcription factor, this work used an oligonucleotide array to identify p53 target genes that are differentially regulated in copper-loaded neurons. Arrays representing 145 human genes expressed downstream of
p53
were hybridized with labeled mRNA from control and copper-treated neurons. Differentially regulated mRNAs included those involved in the regulation of the cell cycle, cytoprotective mechanisms, and apoptotic mechanisms. Transfection of cells with a dominant-negative
p53
construct enabled us to determine which molecular events were dependent on
p53
expression. Copper treatment resulted in the upregulation of p21, reprimo, stathmin, and Tp53INP1, all known to participate in cell cycle arrest. Protective mechanisms included the upregulation of stat-3, and the heat-shock proteins, heat-shock protein (Hsp) 70 and Hsp 27. Both
p53
-dependent and -independent mechanisms leading to apoptosis were identified including insulin-like growth factor binding protein-6, glutathione peroxidase, bcl-2, RB-1,
PUMA
, and several members of the redox active PIG family of proteins. Thus it appears that following copper-mediated neuronal DNA damage, the regulation of a variety of pro- and antiapoptotic genes are responsible for determining neuronal fate.
...
PMID:Expression profiling of p53-target genes in copper-mediated neuronal apoptosis. 1639 88
Endoplasmic reticulum (ER) stress-induced apoptosis has been implicated in the development of multiple diseases. However, the in vivo signaling pathways are still not fully understood. In this report, through the use of genetically deficient mouse embryo fibroblasts (MEFs) and their matched wild-type controls, we have demonstrated that the mitochondrial apoptotic pathway mediated by Apaf-1 is an integral part of ER stress-induced apoptosis and that ER stress activates different caspases through Apaf-1-dependent and -independent mechanisms. In search of the molecular link between ER stress and the mitochondrial apoptotic pathway, we have discovered that in MEFs, ER stress selectively activates BH3-only proteins
PUMA
and NOXA at the transcript level through the tumor suppressor gene
p53
. In
p53
(-/-) MEFs, ER stress-induced apoptosis is partially suppressed. The
p53
-independent apoptotic pathway may be mediated by C/EBP homologous protein (CHOP) and caspase-12, as their activation is intact in
p53
(-/-) MEFs. In multiple MEF lines,
p53
is primarily nuclear and its level is elevated upon ER stress. To establish the role of NOXA and
PUMA
in ER stress-induced apoptosis, we have shown that, in MEFs deficient in NOXA or
PUMA
, ER stress-induced apoptosis is reduced. Reversibly, overexpression of NOXA or
PUMA
induces apoptosis as evidenced by the activation of BAK and caspase-7. Our results provide new evidence that, in MEFs, in addition to
PUMA
,
p53
and NOXA are novel components of the ER stress-induced apoptotic pathway, and both contribute to ER stress-induced apoptosis.
...
PMID:Endoplasmic reticulum stress-induced apoptosis: multiple pathways and activation of p53-up-regulated modulator of apoptosis (PUMA) and NOXA by p53. 1640 91
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>